Neurones Financial Statements From 2010 to 2024
| NRO Stock | EUR 44.90 0.05 0.11% |
Check Neurones financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neurones' main balance sheet or income statement drivers, such as , as well as many indicators such as . Neurones financial statements analysis is a perfect complement when working with Neurones Valuation or Volatility modules.
Neurones |
Neurones Company Return On Equity Analysis
Neurones' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Neurones Return On Equity | 0.14 |
Most of Neurones' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neurones is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Neurones has a Return On Equity of 0.1403. This is 101.17% lower than that of the IT Services sector and 96.97% lower than that of the Information Technology industry. The return on equity for all France stocks is 145.26% lower than that of the firm.
Neurones Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Neurones's current stock value. Our valuation model uses many indicators to compare Neurones value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neurones competition to find correlations between indicators driving Neurones's intrinsic value. More Info.Neurones is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Neurones is roughly 1.82 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Neurones by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Neurones' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Neurones Financial Statements
Neurones stakeholders use historical fundamental indicators, such as Neurones' revenue or net income, to determine how well the company is positioned to perform in the future. Although Neurones investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neurones' assets and liabilities are reflected in the revenues and expenses on Neurones' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neurones. Please read more on our technical analysis and fundamental analysis pages.
Neurones S.A., an information technology services company, provides infrastructure, application, and consulting services in France and internationally. Neurones S.A. was founded in 1985 and is headquartered in Nanterre, France. NEURONES operates under Information Technology Services classification in France and is traded on Paris Stock Exchange. It employs 5160 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Neurones Stock
Neurones financial ratios help investors to determine whether Neurones Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Neurones with respect to the benefits of owning Neurones security.